Haiyue Jin

Ms. Haiyue Jin


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in Journal of Craniovertebral Junction and Spine
Verified
Journal Article
Open access
HJHaiyue Jin
Haiyue Jin
RHRyan Hoang
Ryan Hoang
ACArthur W. Cowman
Arthur W. Cowman
JSJunho Song
Junho Song
THTimothy Hoang
Timothy Hoang
AKAusten D. Katz
Austen D. Katz
Background: The Barricaid annular closure device (Intrinsic Therapeutics, Inc., Woburn, MA) functions to prevent reherniation in patients undergoing primary discectomies for L4-L5 or L5-S1 disc herniation with large annular defects. However, there are limited investigations assessing patient safety. This study analyzed clinical data on device malfunctions and adverse events to inform potential areas for improvements. Methods: Adverse event reports related to the Barricaid device filed from January 1, 2020, to February 28, 2025, were retrieved from the U. S. Food and Drug Administration Manufacturer and User Facility Device Experience database. Event date, device type, device malfunction, and adverse event were recorded. Results: 101 adverse event reports were included in this study. The most common malfunction was device migration (30.7%), followed by unsuccessful implantations (26.7%), which were addressed either intraoperatively (22.8%) or in revision surgeries (4.0%). Reherniation was the most frequently reported device-related adverse event (36.6%), while other postoperative complications were anticipated following spine surgeries that involved implants. Revision surgeries were performed in 67 reports following discoveries of device malfunction and/or adverse events (66.3%). 46 reoperations involved partial or complete device removal (45.5%). Conclusion: Device malfunctions and adverse events inform the importance of careful patient selection, meticulous device handling, and improved device design in enhancing patient safety and outcomes. Patients with frailty, comorbidities, or postimplant adverse events could be subject to increased morbidity and reoperations. Continued postmarketing improvements are needed to mitigate device malfunctions and adverse events.

6 December 2025 in European Spine Journal
Verified
Journal Article
Open access
PDF file
RHRyan Hoang
Ryan Hoang
ACArthur Wesley Cowman
Arthur Wesley Cowman
HJHaiyue Jin
Haiyue Jin
PTPhanisri Tummala
Phanisri Tummala
LLLauren Liu
Lauren Liu
ATAlekos A. Theologis
Alekos A. Theologis
Background Thoracic pedicle subtraction osteotomies (T-PSO) are used to correct severe primary and revision thoracic spinal deformities. While lumbar PSOs are well established, literature describing the efficacy and safety of T-PSOs remains limited. This systematic review aims to characterize indications, correction magnitudes, and complications associated with T-PSO. Methods A systematic review was conducted across PubMed, Web of Science, and Scopus in accordance with PRISMA guidelines. Studies were included if they reported outcomes specific to T-PSO in either primary or revision surgeries. Surgical correction characteristics, thoracic region sub-analyses, and adverse events were summarized. Results Data were extracted from 52 studies, including 38 case reports/series and 14 retrospective chart reviews. Among 404 T-PSO patients, 167 patients had the level of procedure reported. Most procedures were single-level osteotomies (n = 161, 96.4%), with the most frequent levels at T11 and T12. The most common indications for T-PSO based on thoracic region were postoperative kyphosis (n = 15, 32.6%) for the upper thoracic spine, thoracic kyphosis (n = 3, 37.5%) alongside thoracic kyphoscoliosis (n = 3, 37.5%) for the middle thoracic spine, and thoracolumbar kyphosis (n = 54, 50.5%) for the lower thoracic spine. Mean magnitude of thoracic kyphosis correction was 25.8° and correction at the T-PSO level was 25.5°. Adverse events occurred in 48.5% of patients, including structural complications (22.5%), instrumentation failures (11.8%), infections (10.8%), and neurologic deficits (9.8%). Three deaths were reported. Complication rates were similar between primary and revision procedures. Conclusion T-PSO achieves meaningful sagittal plane correction in appropriately selected patients with severe and/or rigid primary and revision thoracic spinal deformities. However, high complication rates emphasize the importance of careful patient selection and surgical planning. Standardization of outcome reporting is critical to optimize future clinical guidance.

27 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RHRyan Hoang
Ryan Hoang
Junho SongJunho Song
Junho Song
ACArthur Wesley Cowman
Arthur Wesley Cowman
THTimothy Hoang
Timothy Hoang
AYAlexander Yu
Alexander Yu
RPRobert L. Parisien
Robert L. Parisien
Background: Anterior cruciate ligament reconstruction (ACLR), one of the most frequently performed orthopedic procedures, has experienced rising demand and escalating costs, driving efforts to reduce expenses through shorter hospital stays and an increased shift toward outpatient settings. This study aims to evaluate how differing definitions of “outpatient” surgery influence the interpretation of outcomes following ACLR. Methods: ACS-NSQIP was queried for patients undergoing primary ACL reconstruction between 2014 and 2023. Patients ≥ 18 years with CPT code 29888 were included. Patients with missing hospital length of stay (LOS) data or a LOS > 2 days (≥99th percentile) were excluded. Two definitions of “outpatient” surgery were evaluated: hospital-defined outpatient (HDO) and same-day discharge (SDD, LOS = 0). Propensity score matching of baseline demographics and comorbidities was used to compare HDO and SDD cohorts to their respective inpatient counterparts. Primary outcomes analyzed included 30-day readmission, reoperation, and postoperative complications. Univariate and multivariate analyses were performed to compare risks of complications for HDO and SDD cohorts compared to their inpatient counterparts. Results: A total of 37,546 patients were included in this study, with 35,334 HDO (94.1%) and 34,801 (92.7%) SDD cases. 1021 (2.9%) of the 35,334 HDO patients had an inpatient hospital stay of at least 1 night. In propensity-matched cohorts, hospital-defined inpatient ACLR was associated with significantly greater risk of 30-day reoperation (odds ratio [OR] 3.167, 95% CI 1.267–7.915, p = 0.009) and superficial surgical site infection (SSI) (OR 5.0, 95% CI 1.712–14.604 p = 0.001), while HDO ACLR was associated with increased risk of deep vein thrombosis (DVT) (OR 0.333, 95% CI 0.121–0.916, p = 0.025). Compared to the propensity-matched SDD cohort, inpatient ACLR was significantly associated with greater rates of 30-day readmission (OR 1.988, 95% CI 1.088–3.630, p < 0.001), reoperation (OR 3.222, 95% CI 1.528–6.794, p = 0.001), and superficial SSI (OR 3.286, 95% CI 1.412–7.644, p = 0.003). Conclusions: This study found differences in readmission and deep vein thrombosis between HDO and SDD cohorts when compared to inpatient ACLR. A standardized definition of outpatient surgery should be created to clearly distinguish same-day discharge from other outpatient categories, considering discharge timing and patient monitoring practices.